
    
      Subjects will be randomized to one of two groups. Group A, (Test Lens, Model SC9) or Group B,
      (Control Lens, Model LI61SE, Bausch and Lomb).

      Both groups will be randomized to receive either unilateral or bilateral implantation. No
      bilateral implantation is allowed in Phase 1. (50 subjects).

      Subjects will be followed for 36 Months.
    
  